News
-
CSL and Lilly team up on ESKD drug
Thursday | Feb 19 2026CSL and Eli Lilly have entered into a licensing agreement on the development and commercialisation of clazakizumab, an interleukin-6 (IL-6) inhibitor monoclonal antibody.
-
Weight loss pills ingredient may be risky
Thursday | Feb 19 2026A NEW study from Adelaide University suggests that a key ingredient in tablet versions of blockbuster weight loss drugs, salcaprozate sodium (SNAC), may have measurable adverse biological effects for the gut and beyond.
-
Dispensary Corner 19 Feb 26
Thursday | Feb 19 2026IN A scandal dubbed 'penisgate', it seems Olympic ski jumpers have allegedly been injecting hyaluronic acid you-know-where in order to fly further.
-
PD breaking news – Priceline records strong 1H 2025-26 results
Thursday | Feb 19 2026Wesfarmers has released its first half year financial results for 2025-26, with the Wesfarmers Health division.
-
Call for real-time shortages guide
Wednesday | Feb 18 2026AS MEDICINE shortages increasingly force frontline clinical staff into high-stakes treatment decisions that can put patient safety at risk, Advanced Pharmacy Australia (AdPha) has called on the Federal Government to establish a real-time clinical guidance service to assist healthcare professionals in managing medicine supply disruptions.
-
Action needed on deprescribing barriers
Wednesday | Feb 18 2026RESEARCH led by Monash University and published in the British Journal of Clinical Pharmacology has found that while most community pharmacists routinely dispense high risk psychotropic medicines, fewer than half initiated discussions on deprescribing.
-
Global full scope perspectives
Wednesday | Feb 18 2026INTERNATIONAL pharmacy leader and Canadian pharmacist, Christine Hrudka, will return to APP in 2026 to share her strategic insights on expanding pharmacy scope of practice.
-
PHI premiums up
Wednesday | Feb 18 2026HEALTH Minister Mark Butler yesterday announced an average private health insurance premium increase of 4.41%, effective from 01 Apr 2026.
-
New CEO for Sanofi
Wednesday | Feb 18 2026FRENCH pharma giant Sanofi has announced former Merck KGaA CEO Belen Garijo as its new CEO, taking over from Paul Hudson whose tenure was ended early.
-
Speeding up heart valve response with SLOW
Wednesday | Feb 18 2026LEADING heart charity Hearts4heart is launching its 'SLOW Symptoms' campaign during Heart Valve Disease Awareness Week (16-22 Feb 2026) in an effort to change Australia's dangerously slow response to heart valve disease.
